Emerging benzimidazole resistance in human hookworms
人类钩虫中出现的苯并咪唑耐药性
基本信息
- 批准号:10159191
- 负责人:
- 金额:$ 41.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-09 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAfricaAfrica South of the SaharaAlbendazoleAnemiaBindingBinding ProteinsBiologyBloodChildChronicCommunicable DiseasesCommunitiesCountryDataDevelopmentDoseDrug ToleranceDrug usageEffectivenessEnvironmentEpidemiologyExposure toFrequenciesGene ExpressionGene FrequencyGenesGenetic MarkersGenetic StructuresGenomic DNAGenotypeGhanaHIVHealth PolicyHelminthsHookworm InfectionsHookwormsHumanImpaired cognitionIn VitroIndividualInstitutionIntestinesKnowledgeLaboratoriesLivestockMalariaMalnutritionMapsMaternal and Child HealthMediatingMedicineMethodsMolecularMonitorMorbidity - disease rateMunicipalitiesMutationNecator americanusNematodaOutcomeParasitesParasitologyPharmaceutical PreparationsPopulationPredispositionPublic HealthResearchResearch PersonnelResearch TrainingResistanceResourcesRiskSamplingSchool-Age PopulationSingle Nucleotide PolymorphismSoilSpatial DistributionStructureSurveysTestingTreatment FailureTuberculosisUniversitiesVulnerable PopulationsWorkWorld Health Organizationbasebenzimidazolebenzimidazole resistancebeta Tubulindisorder controleggexposed human populationfeedingfield studyglobal healthhealth practicehelminth infectionhigh risk populationin vitro Assayneglected tropical diseasespreventprogramsresistance alleleresistance frequencyresponsestructural biologytooltranslational approachtransmission processtreatment response
项目摘要
Project Summary
Hookworm infection is a leading cause of anemia and malnutrition in poor countries, especially in sub-Saharan
Africa. The World Health Organization recommends repeated Mass Drug Administration of benzimidazole
anthelminthics to high risk groups, including school age children, as a way to control morbidity and reduce
transmission of hookworm and other Soil Transmitted Helminths. Although it is anticipated that hookworm
resistance to benzimidazoles will eventually emerge, little is known about the frequency or distribution of
resistant genotypes, as well as the potential for repeated anthelminthic exposure to reduce the effectiveness of
deworming in human populations. Since 2007, the Ghana-Yale Partnership for Global Health has carried out
collaborative field studies on hookworm epidemiology and deworming response, first in Kintampo North
Municipality (KNM) and more recently Kpandai District (KD). Studies in adults and school age children (2007-
2015) have demonstrated reduced efficacy of albendazole, and preliminary data confirm the presence of
putative benzimidazole resistance markers in N. americanus hookworms. We hypothesize that the mechanism
of hookworm treatment failure in Kintampo involves genetically mediated resistance to albendazole. In Specific
Aim 1, deworming effectiveness will be correlated with albendazole susceptibility using N. americanus isolates
from KNM and KD in a field adapted in vitro assay. In Specific Aim 2, genomic DNA from hookworm field
isolates will be used to define the temporal and spatial distribution of known benzimidazole resistance markers,
as well as the genotypes associated with in vitro resistance and treatment failure. Studies in Specific Aim 3 will
establish the structural basis of benzimidazole binding to hookworm β tubulin, as well as map the functional
significance of putative resistance associated mutations. Finally, in Specific Aim 4 the effect of benzimidazole
exposure on hookworm gene expression will be characterized using stage specific cultures of field adapted
and laboratory strains of human parasites. In addition to creating new knowledge to promote Neglected
Tropical Disease control, this project will provide a framework for ongoing collaborative research and training,
building on the record of the Ghana-Yale Partnership for Global Health. Ultimately, development of molecular
methods to elucidate the mechanisms of deworming treatment failure will bridge a pressing technological gap
and fill a critical public health need in Ghana and other resource limited countries.
项目概要
钩虫感染是贫穷国家(尤其是撒哈拉以南地区)贫血和营养不良的主要原因
非洲。世界卫生组织建议重复进行苯并咪唑大规模药物管理
对高危人群(包括学龄儿童)使用驱虫药,作为控制发病率和减少发病率的一种方法
钩虫和其他土传蠕虫的传播。尽管预计钩虫
对苯并咪唑的耐药性最终会出现,但人们对这种耐药性的频率或分布知之甚少。
耐药基因型,以及反复接触驱虫药可能会降低其有效性
对人群进行驱虫。自 2007 年以来,加纳-耶鲁全球健康伙伴关系开展了
关于钩虫流行病学和驱虫反应的合作实地研究,首先在金坦波北
市政府 (KNM) 和最近的 Kpandai 区 (KD)。针对成人和学龄儿童的研究(2007-
2015)已证明阿苯达唑的功效降低,初步数据证实存在
美洲钩虫中假定的苯并咪唑抗性标记。我们假设该机制
金坦波的钩虫治疗失败的一个原因是基因介导的对阿苯达唑的耐药性。具体来说
目标 1,使用美洲奈瑟菌分离株的驱虫效果与阿苯达唑敏感性相关
来自 KNM 和 KD 在现场适应的体外测定中。在具体目标 2 中,来自钩虫领域的基因组 DNA
分离株将用于定义已知苯并咪唑抗性标记物的时间和空间分布,
以及与体外耐药性和治疗失败相关的基因型。具体目标 3 的研究将
建立苯并咪唑与钩虫β微管蛋白结合的结构基础,并绘制功能图谱
假定的耐药性相关突变的重要性。最后,具体目标4中苯并咪唑的作用
钩虫基因表达的暴露将使用田间适应的阶段特定培养物来表征
和人类寄生虫的实验室菌株。除了创造新知识来促进被忽视的
热带病控制,该项目将为正在进行的合作研究和培训提供一个框架,
以加纳-耶鲁全球健康伙伴关系的记录为基础。最终,分子技术的发展
阐明驱虫治疗失败机制的方法将弥合紧迫的技术差距
满足加纳和其他资源有限国家的关键公共卫生需求。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Plasmodium falciparum coinfection is associated with improved IgE and IgG3 response against hookworm antigens.
- DOI:10.1002/hsr2.672
- 发表时间:2022-07
- 期刊:
- 影响因子:2
- 作者:Sakyi, Samuel A.;Wilson, Michael D.;Adu, Bright;Opoku, Stephen;Brewoo, Antwi;Larbi, Amma;Baafour, Emmanuel K.;Tchum, Samuel K.;Saahene, Roland O.;Aniagyei, Wilfred;Sewor, Christian;Courtin, David;Cappello, Michael;Gyan, Ben;Amoani, Benjamin
- 通讯作者:Amoani, Benjamin
Application of multiplex amplicon deep-sequencing (MAD-seq) to screen for putative drug resistance markers in the Necator americanus isotype-1 β-tubulin gene.
- DOI:10.1038/s41598-022-15718-1
- 发表时间:2022-07-06
- 期刊:
- 影响因子:4.6
- 作者:George, Santosh;Suwondo, Peter;Akorli, Jewelna;Otchere, Joseph;Harrison, Lisa M.;Bilguvar, Kaya;Knight, James R.;Humphries, Debbie;Wilson, Michael D.;Caccone, Adalgisa;Cappello, Michael
- 通讯作者:Cappello, Michael
Comparison of percutaneous vs oral infection of hamsters with the hookworm Ancylostoma ceylanicum: Parasite development, pathology and primary immune response.
- DOI:10.1371/journal.pntd.0010098
- 发表时间:2022-01
- 期刊:
- 影响因子:3.8
- 作者:Bungiro RD;Harrison LM;Dondji B;Cappello M
- 通讯作者:Cappello M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL CAPPELLO其他文献
MICHAEL CAPPELLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL CAPPELLO', 18)}}的其他基金
Defining serologic correlates of human hookworm infection
定义人类钩虫感染的血清学相关性
- 批准号:
10667901 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Translational studies of hookworm infection in Ghana
加纳钩虫感染的转化研究
- 批准号:
10580854 - 财政年份:2022
- 资助金额:
$ 41.88万 - 项目类别:
Translational studies of hookworm infection in Ghana
加纳钩虫感染的转化研究
- 批准号:
10446294 - 财政年份:2022
- 资助金额:
$ 41.88万 - 项目类别:
Emerging benzimidazole resistance in human hookworms
人类钩虫中出现的苯并咪唑耐药性
- 批准号:
9920667 - 财政年份:2017
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
7007699 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
6866105 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
7547032 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
7463266 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
7156995 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
The role of MIF in hookworm infection and disease
MIF 在钩虫感染和疾病中的作用
- 批准号:
7337093 - 财政年份:2005
- 资助金额:
$ 41.88万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 41.88万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)